DRUG · Mapped RxNorm record
Modafinil
Normalized identity: modafinil View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
NCT00546403
Study summary
ClinicalTrials.govModafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
ModafinilDRUG · verified · RxNorm: modafinil
PlaceboDRUG
Sponsors & collaborators
Veterans Medical Research Foundationlead sponsor
Cephaloncollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00546403 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.